SAFETY AND EFFICACY OF VINORELBINE PLUS LOW-DOSE METRONOMIC CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES AND TAXANES

被引：1
|
作者：
Kudo, S. [1 ]
Makino, T. [1 ]
Hasunuma, A. [1 ]
Ahiko, Y. [1 ]
机构：
[1] Yamagata Prefectural Cent Hosp, Yamagata, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu329.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
406P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
    M. Campone
    N. Isambert
    E. Bourbouloux
    H. Roché
    J. Bonneterre
    G. Milano
    P. Fumoleau
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 871 - 879
  • [42] Population Pharmacometric Analyses of Eribulin in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
    Majid, Oneeb
    Gupta, Anubha
    Reyderman, Larisa
    Olivo, Martin
    Hussein, Ziad
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1134 - 1143
  • [43] Efficacy and Safety of Low-Dose Oral Etoposide Combined With Capecitabine for Patients With Postoperative Metastatic Breast Cancer Resistant to Anthracycline/Taxanes
    Chen, Xue
    He, Yingjian
    Fan, Tie
    Wei, Yan
    THORACIC CANCER, 2025, 16 (03)
  • [44] A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Estevez, Laura G.
    Batista, Norberto
    Sanchez-Rovira, Pedro
    Velasco, Amalia
    Provencio, Mariano
    Leon, Ana
    Domine, Manuel
    Cruz, Josefina
    Rodriguez, Milva
    CLINICAL BREAST CANCER, 2008, 8 (02) : 149 - 154
  • [45] Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?
    Altundag, Kadri
    JOURNAL OF BUON, 2021, 26 (03): : 1174 - 1174
  • [46] Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer:: antitumor activity and biological effects
    Colleoni, M
    Orlando, L
    Sanna, G
    Rocca, A
    Maisonneuve, P
    Peruzzotti, G
    Ghisini, R
    Sandri, MT
    Zorzino, L
    Nolè, F
    Viale, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 232 - 238
  • [47] Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer
    Saloustros, E.
    Kalbakis, K.
    Vardakis, N.
    Kalykaki, A.
    Milaki, G.
    Rovithi, M.
    Agelaki, S.
    Saridaki, Z.
    Georgoulias, V.
    Mavroudis, D.
    JOURNAL OF BUON, 2011, 16 (02): : 215 - 218
  • [48] Metronomic cyclophosphamide and methotrexate for breast cancer: Enhanced efficacy by adding dalteparin and low-dose prednisone?
    Buckman, Robert
    BREAST, 2011, 20 (05): : 483 - 484
  • [49] The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells
    Krajnak, Slavomir
    Loewe, Amelie
    Battista, Marco Johannes
    Hasenburg, Annette
    Heimes, Anne-Sophie
    Schmidt, Marcus
    Schwab, Roxana
    Brenner, Walburgis
    ANTICANCER RESEARCH, 2021, 41 (03) : 1243 - 1250
  • [50] Combination cyclophosphamide - UFT metronomic low-dose chemotherapy for the treatment of metastatic breast cancer: A preclinical analysis
    不详
    BREAST, 2005, 14 : S4 - S5
12345